Show simple item record

dc.contributor.authorMartin‐Benlloch, Xavier
dc.contributor.authorLanfranchi, Don Antoine
dc.contributor.authorHaid, Sibylle
dc.contributor.authorPietschmann, Thomas
dc.contributor.authorDavioud‐Charvet, Elisabeth
dc.contributor.authorElhabiri, Mourad
dc.date.accessioned2021-07-28T15:00:24Z
dc.date.available2021-07-28T15:00:24Z
dc.date.issued2021-07-02
dc.identifier.citation(2021). European Journal of Inorganic Chemistry, doi:10.1002/ejic.202100341.en_US
dc.identifier.issn1434-1948
dc.identifier.doi10.1002/ejic.202100341
dc.identifier.urihttp://hdl.handle.net/10033/622965
dc.description.abstractLadanein (noted FOMe) is a potent antiviral flavone that was shown to be active on a broad spectrum of enveloped viruses. This 5,6,7-trihydroxylated flavone has, however, pharmacokinetic properties and a half-life time that need to be improved for possible therapeutic applications. We herein took advantage of the complexation properties of ladanein (Fe(III)) to evaluate its ability to bind Mg(II) (biologically relevant and redox inert ion) precursors prepared beforehand from various carboxylic acids. The 5,6,7-trihydroxylated pattern of ladanein and the ligands borne by the Mg(II) atom of the precursors were found to be essential for firm Mg(II) binding. In particular, a ternary Mg(II) complex of ladanein and pidolate (noted FOMe.MgPid) was isolated and considered for its pharmacokinetic and virucidal (Hepatitis C Virus - HCV) properties. Mg(II) complexation significantly improved the physico-chemical (solubility) and the pharmacokinetic properties (clearance, plasmatic concentration) of the flavone FOMe, while not altering its anti-HCV capacity.en_US
dc.description.sponsorshipUniversité de Strasbourgen_US
dc.language.isoenen_US
dc.publisherWiley-VCHen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://onlinelibrary.wiley.com/termsAndConditions#vor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectInorganic Chemistryen_US
dc.titleMagnesium Complexes of Ladanein: A Beneficial Strategy for Stabilizing Polyphenolic Antiviralsen_US
dc.typeArticleen_US
dc.identifier.eissn1099-0682
dc.contributor.departmentTWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.en_US
dc.identifier.journalEuropean Journal of Inorganic Chemistryen_US
dc.identifier.pii10.1002/ejic.202100341
dc.source.volume2021
dc.source.issue27
dc.source.beginpage2764
dc.source.endpage2772
dc.source.journaltitleEuropean Journal of Inorganic Chemistry


Files in this item

Thumbnail
Name:
Martin-Benlloch et al.pdf
Size:
3.381Mb
Format:
PDF
Description:
accepted manuscript

This item appears in the following Collection(s)

Show simple item record